Alphastreet https://validator.w3.org/feed/docs/rss2.html Caterpillar Inc (CAT) Sec Form 8K Conagra Brands, Inc (CAG) Conagra Brands Appoints John Brase as President and Chief Executive Officer Millennium Management Expands Walmart Stake as Digital Sales and Ad Revenue Accelerate Fair Isaac Corporation (FICO) Fair Isaac Corporation Investigated on Behalf of Investors – Contact the DJS Law Group to Discuss Your Rights – FICO GXO Logistics Inc (GXO) Q1 2026 Earnings Call GXO Logistics Inc (GXO) Q1 2026 Earnings Announcement Otis Worldwide Corp (OTIS) Otis Takes Majority Stake in WeMaintain, Supporting Growth and Innovation in Service Technology PTC Inc (PTC) Q2 2026 Earnings Call PTC Inc (PTC) Q2 2026 Earnings Announcement Old Republic International Corporation (ORI) Lodestar launches as independent brand for old republic’s third party administrator business Merck & Co., Inc. (MRK) Ifinatamab Deruxtecan Granted Priority Review in the U.S. for Adult Patients with Previously Treated Extensive-Stage Small Cell Lung Cancer who Experienced Disease Progression on or After Platinum-Based Chemotherapy Broadridge Financial Solutions, inc (BR) Broadridge Launches Next-Generation Digital Asset Capabilities for Canadian Wealth Management Firms Bruker Corp (BRKR) Bruker Unveils New NMR Products and Workflow Solutions at ENC 2026 Broadridge Financial Solutions, inc (BR) Broadridge Launches Next-Generation Digital Asset Capabilities for Canadian Wealth Management Firms Viatris Inc (VTRS) Q1 2026 Earnings Call Dollar General Corporation (DG) DG Media Network to Introduce AI-Enabled In-Store Audio Network Across Thousands of Dollar General Stores Fastenal Co (FAST) Q1 2026 Earnings Call Fastenal Co (FAST) Q1 2026 Earnings Results ANI Pharmaceuticals, Inc (ANIP) ANI Pharmaceuticals Announces the Launch of Carbamazepine Extended-Release Capsules Halliburton Company (HAL) YPF Awards Halliburton Multibillion-dollar Long-term Unconventional Completions Contract in Argentina Eli Lilly and Company (LLY) Lilly’s Jaypirca (pirtobrutinib) significantly extended progression-free survival when added to a venetoclax time-limited regimen in patients with previously treated CLL/SLL Key highlights from Fastenal’s (FAST) Q1 2026 earnings results Ventas, Inc (VTR) Citi 2026 Global Property CEO Conference Merck & Co., Inc. (MRK) Goldman Sachs 45th Annual Global Healthcare Conference Invesco Ltd (IVZ) Superstate and Invesco Expand Strategic Partnership PARSONS CORP (PSN) Parsons Selected to Lead Design of $409M Roosevelt Bridge Replacement SiTime Corporation Jumps 5.2% in Broad Rally Medtronic PLC (MDT) Q4 2026 Earnings Call Medtronic PLC (MDT) Q4 2026 Earnings Announcement Axon Enterprise, Inc. (AXON) Sec Form 8K Bruker Corp (BRKR) Sec Form 8K Expedia Group Inc (EXPE) Sec Form 8K AppFolio, Inc (APPF) Sec Form 8K Artisan Partners Asset Management Inc (APAM) Sec Form 8K News Corp Class A (NWSA) Sec Form 8K Gap Inc (GAP) Q4 2025 Earnings Call Transcript Alphabet Inc. (GOOGL) Sec Form 8K The Kraft Heinz Co (KHC) The Best Reservation in Town is Now at Home with All-New Kraft Mac & Cheese Restaurant Edition Citigroup Inc (C) Q1 2026 Earnings Call Arrowhead Pharmaceuticals, Inc (ARWR) Leerink 2026 Global Healthcare Conference Danaher Corporation (DHR) Beckman Coulter Diagnostics Earns CE Mark for New Assay Delivering Bacterial vs. Viral Infection Results in Approximately 20 Minutes Fti Consulting Inc (FCN) FTI Consulting Appoints Benedict Brogan to Strategic Communications Segment Baker Hughes Co (BKR) Baker Hughes Announces Sale of Waygate Technologies to Hexagon Regeneron Pharmaceuticals Inc (REGN) Dupixent® (dupilumab) Approved in the EU as the First Targeted Medicine to Treat Young Children with Chronic Spontaneous Urticaria (CSU) Uber Technologies Inc (UBER) An Introduction to UberDoc Coinbase Global Inc (COIN) Sec Form 8K Gap Inc (GAP) Q4 2025 Earnings Call Coinbase Global Inc (COIN) Sec Form 8K Nordson Corporation (NDSN) Nordson Electronics Solutions Wins the EM China Innovation Award for Best Supplier of the Year AbbVie (ABBV) AbbVie Showcases Late‑Breaking Phase 2 Data for Mirvetuximab Soravtansine-gynx (ELAHERE®) in Platinum‑Sensitive Ovarian Cancer (PSOC) at SGO 2026